Vanguard Group’s Lucid Diagnostics LUCD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.75M | Buy |
4,127,278
+3,238,404
| +364% | +$3.72M | ﹤0.01% | 3235 |
|
|
2025
Q1 | $1.32M | Buy |
888,874
+327,959
| +58% | +$489K | ﹤0.01% | 3628 |
|
|
2024
Q4 | $459K | Hold |
560,915
| – | – | ﹤0.01% | 3969 |
|
|
2024
Q3 | $457K | Hold |
560,915
| – | – | ﹤0.01% | 3993 |
|
|
2024
Q2 | $460K | Hold |
560,915
| – | – | ﹤0.01% | 4032 |
|
|
2024
Q1 | $454K | Buy |
560,915
+228,524
| +69% | +$185K | ﹤0.01% | 4041 |
|
|
2023
Q4 | $469K | Buy |
332,391
+6,825
| +2% | +$9.62K | ﹤0.01% | 4049 |
|
|
2023
Q3 | $381K | Buy |
325,566
+5,733
| +2% | +$6.71K | ﹤0.01% | 4131 |
|
|
2023
Q2 | $445K | Buy |
319,833
+400
| +0.1% | +$556 | ﹤0.01% | 4151 |
|
|
2023
Q1 | $447K | Hold |
319,433
| – | – | ﹤0.01% | 4151 |
|
|
2022
Q4 | $434K | Buy |
319,433
+67
| +0% | +$91 | ﹤0.01% | 4139 |
|
|
2022
Q3 | $489K | Buy |
319,366
+32,305
| +11% | +$49.5K | ﹤0.01% | 4214 |
|
|
2022
Q2 | $649K | Sell |
287,061
-25,815
| -8% | -$58.4K | ﹤0.01% | 4218 |
|
|
2022
Q1 | $1.05M | Buy |
312,876
+63,687
| +26% | +$214K | ﹤0.01% | 4190 |
|
|
2021
Q4 | $1.34M | Buy |
+249,189
| New | +$1.34M | ﹤0.01% | 4175 |
|